Source: International Congress 2015 – Outcomes of lung transplantation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Helen Stone (Stoke on Trent, United Kingdom), Helen Stone, Ross Edgar, Richard Thompson, Rob Stockley. Lung transplantation in alpha 1 antitrypsin deficiency. Eur Respir J 2015; 46: Suppl. 59, 4548

Member's Comments

No comment yet.

Related content which might interest you: COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Clinical impact of the complications related to lung transplantation Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Lung clearance index in alpha-1-antitrypsin deficiency - A follow up Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Diagnosis of alpha 1 antitrypsin deficiency in primary care Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Quality of life in obstructive lung diseases Source: Annual Congress 2013 –Various issues in clinical respiratory physiology Year: 2013 Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Heterogeneity in lung function of PiZZ alpha 1 antitrypsin deficiency: Impact of occupation in predicting disease severity Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Assessment of quality of life (SGRQ) in patients with alpha-1-antitrypsin deficiency– Analysis from the German registry Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016 Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Health-related quality of life in emphysema due to alpha-1-antitrypsin deficiency Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Psychological assessment in COPD and lung cancer patients in pulmonary rehabilitation Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity Year: 2015 Chronic obstructive pulmonary disease: How good is GOLD on its own?! Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013 Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 The national alpha-1 antitrypsin deficiency registry in Poland Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Clinical differences between emphysematous and non-emphysematous COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 The NIHR translational research collaboration: The relationship between CT densitometry and quality of life in alpha one antitrypsin deficiency Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016 Effectiveness of a 3-week-in-patient-rehabilitation-program in patients with COPD GOLD-stage IV Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1) Year: 2013